-
公开(公告)号:US20190284295A1
公开(公告)日:2019-09-19
申请号:US16352589
申请日:2019-03-13
发明人: Scott CHAPPEL , Andrew LAKE , Michael WARREN , Austin DULAK , Erik DEVEREAUX , Pamela M. HOLLAND , Tauqeer ZAIDI , Matthew RAUSCH , Bianka Prinz , Nels P. NIELSON , Sonia DAS
摘要: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.
-
公开(公告)号:US20210095041A1
公开(公告)日:2021-04-01
申请号:US17021223
申请日:2020-09-15
发明人: Scott CHAPPEL , Andrew LAKE , Michael WARREN , Austin DULAK , Erik DEVEREAUX , Pamela M. HOLLAND , Tauqeer ZAIDI , Matthew RAUSCH , Bianka Prinz , Nels P. NIELSON , Sonia DAS , Alison M. O'Neill
IPC分类号: C07K16/28 , A61K39/395 , A61P35/00 , A61K45/06 , A61K31/337 , A61K31/7068
摘要: The invention provides anti-CD39 antibody compositions and their use in treating cancer.
-
公开(公告)号:US20220372160A1
公开(公告)日:2022-11-24
申请号:US17642824
申请日:2020-09-15
发明人: Scott CHAPPEL , Andrew LAKE , Michael WARREN , Austin DULAK , Erik DEVEREAUX , Pamela M. HOLLAND , Tauqeer ZAIDI , Matthew RAUSCH , Bianka Prinz , Nels P. NIELSON , Sonia DAS , Alison M. O'Neill
摘要: The invention provides anti-CD39 antibody compositions and their use in treating cancer. In some embodiments, an isolated anti-CD39 antibody is provided. Such an isolated anti-CD39 antibody binds to human CD39, wherein the antibody is optionally fully human or humanized. In some embodiments, the disclosure provides a method of enhancing, increasing and/or sustaining an anti-tumor immune response in a subject comprising administering the antibody or composition described herein to a subject having a tumor.
-
公开(公告)号:US20210363268A1
公开(公告)日:2021-11-25
申请号:US16980271
申请日:2019-03-13
发明人: Scott CHAPPEL , Andrew LAKE , Michael WARREN , Austin DULAK , Erik DEVEREAUX , Pamela M. HOLLAND , Tauqeer ZAIDI , Matthew RAUSCH , Bianka Prinz , Nels P. NIELSON , Sonia DAS
IPC分类号: C07K16/28 , A61K39/395 , A61P35/00 , G01N33/573
摘要: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.
-
公开(公告)号:US20200277394A1
公开(公告)日:2020-09-03
申请号:US15931469
申请日:2020-05-13
发明人: Scott CHAPPEL , Andrew LAKE , Michael WARREN , Austin DULAK , Erik DEVEREAUX , Pamela M. HOLLAND , Tauqeer ZAIDI , Matthew RAUSCH , Bianka Prinz , Nels P. NIELSON , Sonia DAS
摘要: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.
-
-
-
-